Kidney injury in mice slows liver drug clearance, hinting at reno-hepatic crosstalk
- Mouse renal ischemia-reperfusion injury was used to ask how acute kidney injury affects liver-cleared drugs, pitavastatin and antipyrine, dosed before and at early times after injury.
- Kidney filtration collapsed and only partly recovered, while kidney and liver injury markers and a uremic toxin rose and then partly normalized.
- Exposure to both drugs increased after injury; for pitavastatin this fit reduced clearance, whereas antipyrine appeared multifactorial. Liver transcriptomics showed altered metabolizing-enzyme and transporter genes and shifts in tryptophan/kynurenine pathways.
💡 Points Based on the abstract
If a bad kidney can throttle hepatic clearance, then renal function belongs in exposure modelling for liver-cleared drugs, not just renally cleared ones. I'd test this next with a transporter-sensitive probe like pitavastatin before trusting it. The antipyrine result is muddy, and one acute ischemia model says little about chronic kidney disease patients.